Chinese Clinical Oncology

短名Chin. Clin. Oncol.
Journal Impact2.03
国际分区ONCOLOGY(Q3)
ISSN2304-3865, 2304-3873
h-index36

The Chinese Clinical Oncology (Print ISSN 2304-3865; Online ISSN 2304-3873; Chin Clin Oncol; CCO) publishes articles that describe new findings in the field of oncology, and provides current and practical information on diagnosis, prevention and clinical investigations of cancer. Specific areas of interest include, but are not limited to: multimodality therapy, biomarkers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to cancer. The aim of the Journal is to provide a forum for the dissemination of original research articles as well as review articles in all areas related to cancer. It is an international, peer-reviewed journal with a focus on cutting-edge findings in this rapidly changing field. To that end, Chin Clin Oncol is dedicated to translating the latest research developments into best multimodality practice. The journal features a distinguished editorial board, which brings together a team of highly experienced specialists in cancer treatment and research. The diverse experience of the board members allows our editorial panel to lend their expertise to a broad spectrum of cancer subjects.

涉及主题医学生物内科学遗传学病理癌症外科肿瘤科化学生物化学免疫学化疗癌症研究放射科胃肠病学数学基因
出版信息出版商: AME Publishing Company出版周期: 期刊类型: journal
基本数据创刊年份: 2012原创研究文献占比13.79%自引率:4.80%Gold OA占比: 90.58%

期刊引文格式

这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。

并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。

只有1位作者的期刊

有2位作者的期刊

有3位作者的期刊

有5位以上作者的期刊

书籍引用格式

以下是创作和编辑的书籍的参考文献的示例。

学位论文引用格式

网页引用格式

这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。

专利引用格式

最新文章

The landscape of perioperative immunotherapy in non-small cell lung cancer: what have we learned from the AEGEAN trial?

2024-8-1

Accelerated aging and young-onset cancer risk!—are stressors of the PELICan hypothesis the missing link?

2024-8-1

Advancements in artificial intelligence for robotic-assisted radical prostatectomy in men suffering from prostate cancer: results from a scoping review

2024-8-1

AB045. E2F6 promotes temozolomide resistance in glioblastoma by enrichment in CARD6 and POSTN promoter region

2024-8-1

Efficacy and safety of PARP inhibitors in the treatment of prostatic cancer: a systematic review and network meta-analysis

2024-8-1

AB006. The use of magnetic resonance spectroscopy (MRS) in the differential diagnosis of paediatric intracranial tumours

2024-8-1

AB082. Navigating barriers to epilepsy surgery: a national survey of patient and neurologist perspectives

2024-8-1

AB078. Patterns of treatment delay in patients with symptomatic metastatic epidural spinal cord compression

2024-8-1

AB046. Dual role of POSTN in maintaining glioblastoma stem cells and immune- suppressive microglia in glioblastoma

2024-8-1

AB013. Infantile brainstem high grade glioma

2024-8-1

AB053. Lessons from managing an 11-year-old girl with a calvarial neuroblastoma in a resource-limited setting: a case report

2024-8-1

AB012. A phase III randomized trial of gross total resection versus possible resection of FLAIR hyperintensity lesion on MR image for newly diagnosed supratentorial glioblastoma (JCOG2209)

2024-8-1

AB064. Two case reports & review of literature: perioperative surgical management of symptomatic large non-functioning pituitary masses in early pregnancy

2024-8-1

AB074. Propensity-score matched analysis to evaluate the safety and utility of intraoperative cell- salvaged autologous blood transfusion in metastatic spine tumour surgery

2024-8-1

AB010. Analyzing Response Assessment in Neuro-Oncology (RANO) response criteria in WHO grade III anaplastic astrocytomas in comparison to clinician evaluation: case report

2024-8-1

AB079. Whole-brain radiotherapy versus high dose chemotherapy with autologous stem-cell transplantation for consolidation therapy in primary central nervous system lymphoma

2024-8-1

AB014. The accurate classification of high-grade glioma, IDH-wildtype, is based on methylation profiling

2024-8-1

AB034. Medico-legal ethics dilemma in treatment decisions for intracranial metastasis in a young gravida patient: a case report

2024-8-1

AB004. Transsylvian approach for radical resection of insular gliomas: emphasizing the importance of the transsylvian approach for elderly patients with Zone II and III insular gliomas

2024-8-1

AB060. Autophagy-associated biomarkers ULK2, UVRAG, and miRNAs miR-21, miR-126, and miR-374: prognostic significance in glioma patients

2024-8-1

AB032. The effect of high-dose dexamethasone on systemic immune-inflammation index (SII) in patients with brain tumor, a retrospective study in tertiary hospital in Indonesia

2024-8-1

AB033. Factors related to neuropathic pain in spinal metastasis tumor patients experiencing cancer pain at Dr. Cipto Mangunkusumo Hospital

2024-8-1

AB017. NFκB1 regulates FDX1 to facilitate elesclomol-induced cuproptosis against glioblastoma

2024-8-1

AB015. Efficacy and safety of boron neutron capture therapy in managing metastatic spinal tumors: experimental findings

2024-8-1

AB056. Management of a rare case of adult intracranial large temporal mature teratoma in limited neurosurgical care settings: a case report

2024-8-1

AB036. Targeting glioblastoma de-novo purine metabolism to overcome chemoradiation resistance: an interim result of phase 0/1 clinical trial in newly diagnosed and recurrent glioblastoma

2024-8-1

AB062. Investigating miR-21 as a non-invasive prognostic biomarker in glioma patients

2024-8-1

AB030. Combined transcranial and endonasal endoscopic approach for sinonasal tumors with intracranial extension: a case series

2024-8-1

AB092. Imaging the histopathology subtypes of the GH-secreting pituitary neuroendocrine tumor

2024-8-1

AB070. Roles of neutrophil to lymphocyte ratio in differentiating glioblastoma from brain metastasis

2024-8-1

AB065. Basal ganglia germ cell tumor presenting with visual loss in adult: a case report

2024-8-1

AB048. Evidence of effectiveness of neoadjuvant camrelizumab and apatinib in patients with recurrent high-grade gliomas

2024-8-1

AB088. Spinal cord diffuse midline glioma in adults: a case report and literature review

2024-8-1

AB095. Methylation class infant-type hemispheric glioma with CDKN2A/B deletion: a rare case report

2024-8-1

Zolbetuximab on the SPOTLIGHT—a light spot?

2024-8-1

AB080. High-dose methotrexate with and without intra-thecal methotrexate and whole-brain radiotherapy for primary central nervous system lymphoma: a systematic review

2024-8-1

AB025. Efficacy of 5-ALA brightness analysis for malignant brain tumor surgery

2024-8-1

AB069. Type of personality and cancer-related pain in central nervous system (CNS) tumor patients: a cross-sectional study

2024-8-1

AB024. Preoperative and postoperative clinical manifestation, hormonal, and imaging profile of sellar region tumor in Dr. Saiful Anwar General Hospital, East Java: a 1-year cross-sectional study

2024-8-1

AB022. Management of first recurrence or progression of craniopharyngioma after resection alone: a systematic review and individual-participant data meta-analysis

2024-8-1

AB040. A complication of recurrent artery of Huebner infarction after resection of an anterior cerebral artery thrombotic giant intracranial aneurysm: case report and literature review

2024-8-1

AB042. Combined anti-PD-L1 and anti-VEGFR2 therapy promotes the antitumor immune response in glioblastoma multiforme by reprogramming tumor microenvironment

2024-8-1

AB075. When would minimally invasive spinal surgery not be preferable for metastatic spine disease? a narrative review

2024-8-1

AB021. Primary diffuse large B-cell lymphoma of the central nervous system: role of imaging in a rare disease—a case report

2024-8-1

AB087. Rectosigmoid approach for cerebellopontine angle tumors: what have we learned so far?

2024-8-1

AB071. Predictive value of plasma microRNA-10b and microRNA-21 on chemotherapy toxicity, recurrence, and overall survival in high-grade glioma patients treated with temozolomide

2024-8-1

AB089. Improving decision-making in traumatic brain injury patients via 3D volumetric analysis of epidural haematoma

2024-8-1

AB049. Surgery for symptomatic spinal metastases—when, what and how?

2024-8-1

AB009. Distinct clinical profiles and treatment outcomes in invasive pituitary adenoma and Crooke cell tumor: a comparative case study

2024-8-1

AB002. DNA methylation-regulated genes contribute to temozolomide (TMZ) resistance by scaffolding paraspeckle proteins

2024-8-1

帮你贴心管理全部的文献

研飞ivySCI,高效的论文管理

投稿经验分享

分享我的经验,帮你走得更远

Built withby Ivy Science
Copyright © 2020-2024
版权所有:南京青藤格致信息科技有限公司